Allergic Asthma Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Allergic asthma is one of the most common types of asthma. Allergic asthma is triggered by inhaling allergens such as mold, pollen, pet dander, and dust mite allergen resulting in symptoms of allergic asthma which include chest tightness, rapid breathing or shortness of breath, wheezing, and coughing.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the allergic asthma therapeutics market growth in future. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. According to the World Health Organization (WHO), more than 200 million people suffer from COPD and around 235 million have asthma all across the globe.

Allergic asthma therapeutics are cost-effective and gaining popularity among patients and healthcare professionals due to launches of novel drugs by key players. This is estimated to drive the market growth during the forecast period.

Moreover, governments are taking initiatives to provide better care and treatment for patients, and are focusing on increasing awareness about allergic asthma which is contributing to the allergic asthma therapeutics market growth. However, the increasing use of generic drugs and upsurge in patent expiry of drugs are predicted to restrict the market growth in the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global allergic asthma therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
• It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global allergic asthma therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
• Key players covered as a part of this study are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited.
• Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global allergic asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for allergic asthma therapeutics market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Allergic Asthma Therapeutics Market, By Drug Type:

• Corticosteroids
• Bronchodilators
• Leukotriene modifiers
• Immunotherapy
• Biologics
• Others

Global Allergic Asthma Therapeutics Market, By Route of Administration:

• Oral
• Inhaled
• Others

Global Allergic Asthma Therapeutics Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa

Company Profiles

• Aslan Pharmaceuticals, Pte. Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Baxalta Incorporated
• Axikin Pharmaceuticals
• Chiesi Farmaceutici SpA
• CSL Limited
• Circassia Pharmaceuticals Plc
• Fountain Biopharma Inc.
• Hydra Biosciences
• GlaxoSmithKline Plc
• Infinity Pharmaceuticals
• Mabtech Limited
• Kineta
• Marinomed Biotechnologie Gmb
• NeoPharm Co.
• Mycenax Biotech Inc.
• Panacea Biotec Limited
• Oxagen Limited

“*” marked represents similar segmentation in other categories in the respective section.